The Anti-inflammatory Effect of Low-Level Laser Therapy on Experimentally Induced Inflammation of Rabbit Temporomandibular Joint Retrodiscal Tissues

Aims: To investigate the effect of low-level laser therapy (LLLT) on experimentally induced inflammation in retrodiscal tissues of the rabbit temporo mandibular joint (TMJ) using scintigraphic imaging. Methods: Eleven male New Zealand rabbits were included in this study. Six randomly selected rabbits were imaged to provide normal joint images (normal group) before the initiation of the experiment. A 5% formalin solution was locally injected into both right and left TMJs of all rabbits. Subsequently, Ga-Al-As laser (wavelength: 815 nm; energy density: 12 J/cm2; output power: 250 mW) was applied for 48 seconds. The treat-ment was performed six times for 2 weeks to the left TMJ of all rabbits. The right TMJs of the rabbits were used as the control (nontreated) TMJ group, while left TMJs were used as the treated TMJ group. Static images of TMJ were taken at 24 hours, 7 days, and 14 days after the beginning of the treatment. The images of all TMJs were taken in the posteroanterior direction with the rabbit under sedation and its mouth open. The Mann-Whitney U test was used to compare group differences, and intragroup differences were determined by the Friedman test and Wilcoxon sign test. Results: Significant differences were found between normal and both the control and treated TMJ groups. A reduction of inflammation in both treated and control TMJ groups was obtained, but there was no statistically significant difference between the groups. Conclusion: Under the conditions used in this study, quantitative scintigraphic measurements of TMJ inflammation of the treated TMJ group decreased but did not differ significantly from those of the control TMJ group.

aseptic inflammation;experimental study;low-level laser therapy;scintigraphy;temporomandibular joint

1. Okeson JP. Management of Temporomandibular Disorders and Occlusion, ed 6. St Louis: Mosby, 2008.

2. McNeill C. Management of temporomandibular disorders: Concepts and controversies. J Prosthet Dent 1997;77: 510–522.

3. Hansson TL. Infrared laser in the treatment of craniomandibular disorders, arthrogenous pain. J Prosthet Dent 1989;61:614–617.

4. Mazzetto MO, Carrasco TG, Bidinelo EF, de Andrade Pizzo RC, Mazzetto RG. Low intensity laser application in temporomandibular disorders: A phase I double-blind study. Cranio 2007;25:186–192.

5. Venancio Rde A, Camparis CM, Lizarelli Rde F. Low intensity laser therapy in the treatment of temporomandibular disorders: A double-blind study. J Oral Rehabil 2005;32: 800–807.

6. Ferreira DM, Zângaro RA, Villaverde AB, et al. Analgesic effect of He-Ne (632.8 nm) low-level laser therapy on acute inflammatory pain. Photomed Laser Surg 2005;23: 177–181.

7. Fikácková H, Dostálová T, Vosická R, Peterová V, Navrátil L, Lesák J. Arthralgia of the temporomandibular joint and low-level laser therapy. Photomed Laser Surg 2006;24: 522–527.

8. Kulekcioglu S, Sivrioglu K, Ozcan O, Parlak M. Effectiveness of low-level laser therapy in temporomandibular disorder. Scand J Rheumatol 2003;32:114–118.

9. Aimbire F, Albertini R, Pacheco MT, et al. Low-level laser therapy induces dose-dependent reduction of TNFalpha levels in acute inflammation. Photomed Laser Surg 2006; 24: 33–37.

10. Albertini R, Aimbire FS, Correa FI, et al. Effects of differ-ent protocol doses of low power gallium-aluminum-arsenide (Ga-Al-As) laser radiation (650 nm) on carrageenan induced rat paw oedema. J Photochem Photobiol B 2004;74: 101–107.

11. Honmura A, Ishii A, Yanase M, Obata J, Haruki E. Analgesic effect of Ga-Al-As diode laser irradiation on hyperalgesia in carrageenan- induced inflammation. Laser Surg Med 1993;13:463–469.

12. Cetiner S, Kahraman SA, Yücetas S. Evaluation of low-level laser therapy in the treatment of temporomandibular disorders. Photomed Laser Surg 2006;24:637–641.

13. Gray RJM, Quayle AA, Hall CA, Schofield MA. Physiotherapy in the treatment of temporomandibular joint disorders: A comparative study of four treatment methods. Br Dent J 1994;176:257–261.

14. Bertolucci LE, Grey T. Clinical analysis of mid-laser versus placebo treatment of arthralgic TMJ degenerative joints. Cranio 1995;13:26–29.

15. Fikácková H, Dostálová T, Navrátil L, Klaschka J. Effectiveness of low-level laser therapy in temporomandibular joint disorders: A placebo-controlled study. Photomed Laser Surg 2007;25:297–303.

16. Parker S. Low-level laser use in dentistry. Br Dent J 2007;10:131–138.

17. Harper RP, Kerins JE, McIntosh JE, Spears R, Bellinger LL. Modulation of the inflammatory response in the rat TMJ with increasing doses of complete freund’s adjuvant. Osteoarthritis Cartilage 2001;9:619–624.

18. Tominaga K, Alstergren P, Kurita H, Kopp S. Clinical course of an antigen induced arthritis model in the rabbit temporomandibular joint. J Oral Pathol Med 1999;28: 268–273.

19. Goulart AC, Correia FA, Sousa SC, Luz JG. Study of the inflammatory process induced by injection of carrageenan or formalin in the rat temporomandibular joint. Braz Oral Res 2005;19:99–105.

20. Rennen HJ, Corstens FH, Oyen WJ, Boerman OC. New concepts in infection/inflammation imaging. Q J Nucl Med 2001;45:167–173.

21. Coutinho A, Fenyo-Pereira M, Dib LL, Lima EN. The role of SPECT/CT with 99mTc-MDP image fusion to diagnose temporomandibular dysfunction. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:224–230.

22. Liberatore M, Clemente M, Iurilli AP, et al. Scintigraphic evaluation of disease activity in rheumatoid arthritis: A comparison of technetium-99m human non-specific immunoglobulins, leucocytes and albumin nanocolloid. Eur J Nucl Med 1992;19:853–857.

23. Breedveld FC, van Kroonenburgh MJ, Camps JA, Feitsma HI, Markusse HM, Pauwels EK. Imaging of inflammatory arthritis with technetium-99m-labeled IgG. J Nucl Med 1989;30:2017–2021.

24. Pons F, Moyá F, Herranz R, et al. Detection and quantita-tive analysis of joint activity inflammation with 99Tcm-polyclonal human immunoglobulin G. Nucl Med Commun 1993;14:225–231.